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ABSTRACT 
 
OBJECTIVE: To evaluate the association between having a household member with a 
cancer-related limitation (physical, mental, or emotional) and human papillomavirus 
(HPV) vaccine uptake among females aged 9 – 17 years.  
METHODS: We analyzed 2008 National Health Interview Survey for our cross-sectional 
analysis. All households with females aged 9 – 17 years were eligible for inclusion in 
our analysis. Our outcomes of interest included HPV vaccine initiation (≥1 dose) and 
series completion (full 3 doses). A dichotomous variable indicating a cancer-related 
limitation for a household member was created if at least one adult in the household 
responded to having a limitation caused by cancer. We used Firth’s bias-reducing 
penalized likelihood for logistic regression[11] to estimate prevalence odds ratios (ORs) 
and corresponding 95% profile penalized likelihood confidence intervals (CIs) for HPV 
vaccine uptake among young females who had a household member with a cancer-
related limitation compared to young females who did not have a household member 
with a cancer-related limitation after adjusting for child’s age, race/ethnicity, and SES. 
RESULTS: HPV vaccine initiation and completion were higher among females aged 9-
17 years who had a household member with a cancer-related limitation (Initiation: 
OR=1.42, 95%CI: 0.26, 5.18); Completion: OR=2.50, 95%CI: 0.26, 11.58).  
CONCLUSION: Our results suggest that females aged 9 – 17 years in the United 
States who have a household member with a cancer-related limitation (physical, mental, 
or emotional) may be more likely to initiate and complete the HPV vaccination. 
However, our point estimates lack precision (evident by wide confidence intervals) 
because of limited prevalence of the exposure in our study population. 
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INTRODUCTION 
Females aged 9 – 17 years are prime candidates for the quadrivalent human 
papillomavirus (HPV) vaccine to prevent cervical cancer because the vaccine is most 
effective prior to sexual initiation.[1,2] Preventive health behaviors in this age group are 
strongly influenced by family environment.[3-5] For example, the use of preventive 
health services is influenced by having a family member with limitations caused by a 
chronic illness.[6] Therefore, we evaluated whether females aged 9 – 17 years who 
have a household member with a cancer-related limitation (physical, mental, or 
emotional) are more likely to initiate and complete the HPV vaccination. 
 
METHODS 
Data Source 
We utilized data from the 2008 National Health Interview Survey (NHIS), which 
was the first NHIS to incorporate questions regarding HPV vaccine[7]. The NHIS is an 
annual in-person random household survey of the civilian non-institutionalized 
population of the United States.[8] Individual-level health information was ascertained 
using the Family Core survey for participants aged ≥18 years. For households with 
children, one child within the selected household was randomly sampled to complete 
the Sample Child Core survey by a knowledgeable adult proxy. All households with 
females aged 9 – 17 years were eligible for inclusion in our analysis. We linked data for 
each child to the interviewed adult in her household and to relevant demographic and 
socioeconomic variables collected in the Household-Level, Family-Level, and Person-
Level files. 
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Variables 
Our outcomes of interest included HPV vaccine initiation and series completion. 
HPV vaccine initiation was defined as receiving at least one dose of the vaccine, 
whereas HPV vaccine series completion was defined as receiving the full 3 doses of the 
vaccine. HPV vaccine initiation and series completion were ascertained from responses 
to the questions, “Did [the sample child] ever receive the HPV shot or cervical cancer 
vaccine?” and “How many HPV shots did [the sample child] receive?” 
A cancer-related limitation for a household member was ascertained by 
combining data from the survey questions “Are you or any family members limited in 
any way in any activities because of physical, mental, or emotional problems?” and 
“What conditions or health problems cause the person’s limitations?”  A dichotomous 
variable indicating a cancer-related limitation for a household member was created if at 
least one adult in the household responded to having a limitation caused by cancer. 
Data analysis 
We encoded a directed acyclic graph (DAG)[9] based on current evidence 
regarding factors that influence HPV vaccine uptake and their inter-relations to identify a 
minimal sufficient set of covariates for which to adjust in our analyses (Figure 1). 
Covariates that required adjustment (age, race/ethnicity, and socioeconomic status) to 
reduce confounding bias were identified using the back-door criterion[9] in a directed 
acyclic graph. Therefore, we adjusted for child’s age, race/ethnicity, and SES in a 
multivariable regression model. Race/ethnicity was categorized as non-Hispanic White, 
non-Hispanic Black, non-Hispanic Asian, Hispanic, and Other. SES was defined 
according to the education level of the person reported as the head of household (did 
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not graduate from high school, high school graduate, some, college, college graduate or 
more) and family income as a percent of the federal poverty level adjusted for family 
size (<100%, 100%-199%, 200%-399%, ≥ 400%).[10] 
We compared the distribution of demographic and other characteristics between 
females who completed the full series of the HPV vaccine, females who initiated the 
HPV vaccine, and females who did not receive the HPV vaccine. Age was reported as 
medians and corresponding interquartile range (IQR), whereas categorical 
characteristics were reported as proportions. Furthermore, we used Firth’s bias-
reducing penalized likelihood for logistic regression[11] in SAS 9.2 (SAS Institute, Cary, 
NC) to estimate prevalence odds ratios (ORs) and corresponding 95% profile penalized 
likelihood confidence intervals (CIs) for HPV vaccine uptake among young females who 
had a household member with a cancer-related limitation compared to young females 
who did not have a household member with a cancer-related limitation after adjusting 
for child’s age, race/ethnicity, and SES. Penalized logistic regression was used to 
address issues with sparse data and separation [11] in our analyses. 
 
RESULTS  
Our study population consisted of 1,965 females aged 9 – 17 years with a 
median age of 13 years (IQR: 11, 15). Ethnic minorities comprised nearly half of our 
study population (Whites=48.2%, Hispanics=26.4 Blacks=18.2%, Asians=6.2%). The 
highest proportion of females (36.4%) lived in a household where the head of household 
had at least a college degree. Furthermore, 62.8% of females lived in households with a 
family income ≥ 200% of the federal poverty level. The distribution of demographic 
characteristics by vaccine status is detailed in Table 1. 
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The prevalence of HPV vaccine uptake initiation was 19.0% (95% CI: 17.0%, 
21.1%) and the prevalence of HPV series completion (full 3 doses) was 7.8% (95% CI: 
6.4%, 9.3%) in our study population. Females aged 9 – 17 years who had a household 
member with a cancer-related limitation had 42% and 150% higher odds of initiating and 
completing the HPV vaccination, respectively, compared to those who did not have a 
household member with a cancer-related limitation (Initiation: OR=1.42, 95% CI: 0.26, 
5.18; Completion: OR=2.50, 95% CI: 0.26, 11.58). The estimates for HPV vaccine 
initiation and completion are provided in Table 2. 
 
DISCUSSION   
Our results suggest that females aged 9 – 17 years in the United States who 
have a household member with a cancer-related limitation (physical, mental, or 
emotional) may be more likely to initiate and complete the HPV vaccination. However, 
our point estimates lack precision (evident by wide confidence intervals) because of 
limited prevalence of the exposure in our study population. Therefore, the durability of 
our findings is questionable without further analyses in a larger study population. 
Although we did not specifically define family history of cancer as our exposure, our 
study advances this line of research by incorporating severity (limitation attributed to 
cancer) and proximity (living in the household) of cancer in the family as potential 
influences on HPV vaccine uptake. Furthermore, our study provides preliminary 
evidence that cancer within the family may be an important influence on actual HPV 
vaccine uptake and not just HPV vaccine acceptability, as reported in a pre-licensure 
study [12]. 
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Certain limitations of our analyses should be considered for appropriate 
interpretation of our results. Surveys with complex sampling methods, such as NHIS, 
require accounting for the complex survey design in the analyses to estimate 
parameters that can be generalized to the source population[13] (for NHIS, the source 
population is the United States population). However, our analyses required penalized 
methods to reduce bias created by sparse data and separation[11]. Unfortunately, 
penalized methods are currently unavailable for use with complex survey design 
analysis in SAS. We opted to compromise generalizability to the United States 
population for enhanced internal validity through bias reduction. 
In summary, our results suggest that females aged 9 – 17 years in the United 
States who have a household member with a cancer-related limitation may be more 
likely to initiate and complete the HPV vaccination, but the durability of our findings are 
questionable because of few exposed individuals. Although preliminary, our findings 
may be useful for underscoring the important role of family environment on HPV 
vaccination uptake among young females, particularly for families that have 
experienced the debilitating potential of cancer. Given the promise of preventing 
cervical cancer through vaccination and the low prevalence of vaccine uptake observed 
in our study population, the identification of motivated subgroups may be useful for 
directing vaccine promotion efforts to less motivated subgroups that are eligible for the 
HPV vaccine. 
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KEY MESSAGES 
• The 2-year post-licensure prevalence of HPV vaccine initiation and 
completion is relatively low among young females aged 9 – 17 years in our 
study population, which could have implications for vaccine promotion 
efforts. 
• Familial factors may play an important role in HPV vaccine uptake. 
• Identification of motivated subgroups may guide HPV vaccination efforts and 
facilitate efficient allocation of public health resources. 
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Figure 1. Proposed causal structure for the relation between a household member with a 
cancer-related limitation (physical, mental, or emotional) and HPV vaccine uptake 
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Table 1. Characteristics of females aged 9 – 17 years from the 2008 National Health Interview 
Survey. 
Characteristic No doses 
(n=1608) 
Initiation (≥1 dose) 
n=357 
Completion (3 
doses) n=146 
Age, median (IQR)a 13.0 (11.0, 15.0) 15.0 (13.0, 16.0) 13.0 (11.0, 15.0) 
Race/ethnicity, n (%)  
White 755 (47.0) 193 (54.1) 90 (61.6) 
Black 301 (18.7) 56 (15.7) 12 (8.2) 
Asian 105 (6.5) 17 (4.8) 6 (4.1) 
Hispanic 434 (27.0) 84 (23.5) 33 (22.6) 
Other 13 (0.8) 7 (2.0) 5 (3.4) 
Family Income, n (%)  
<100% 231 (15.1) 63 (18.6) 19 (13.6) 
100%-199% 331 (21.7) 68 (20.1) 24 (17.1) 
200%-399% 517 (33.9) 92 (27.2) 43 (30.7) 
≥400% 446 (29.2) 115 (34.0) 54 (38.6) 
Education level of head 
of household, n (%) 
 
Did not graduate HS 287 (18.0) 64 (17.9) 26 (17.8) 
High school graduate 466 (29.2) 73 (20.4) 23 (15.8) 
Some college 286 (17.9) 68 (19.0) 19 (13.0) 
College graduate or 
higher 
559 (35.0) 152 (42.6) 78 (53.8) 
Household member with 
cancer-related limitation, 
n (%) 
11 (0.7) 4 (1.1) 2 (1.4) 
aIQR= Interquartile range 
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Table 2. Prevalence odds ratios for the association between cancer-related physical 
limitations and human papillomavirus vaccine uptake among females aged 9 – 17 years, 
2008 United States National Health Interview Survey. 
HPV vaccine uptake status Unadjusted Odds Ratio 
(95% C.I.) 
Adjusted Odds Ratioa 
(95% C.I.) 
Completion (3 doses) 2.40 
(0.46, 8.23) 
2.50 
(0.26, 11.58) 
Initiation (≥ 1 dose) 1.77 
(0.53, 4.99) 
1.42 
(0.26, 5.18) 
No doses received 1.00 1.00 
aAdjusted for age, race/ethnicity, and socioeconomic status. 
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